Who Paid My Doc
Illuccix
Drug Prostate Cancer Therapy
NDC 74725-100-25
General payments
$1,047,551
Research payments
$254,000
Through program year 2024, $1,047,551 in general payments and $254,000 in research payments were reported against Illuccix (Prostate Cancer Therapy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $527,946 | 2,360 |
| 2023 | General | $422,448 | 2,026 |
| 2022 | General | $97,157 | 520 |
| 2022 | Research | $254,000 | 31 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 54 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
4,906 general · 31 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.